Job Syndrome · What It Is, Causes, Signs and Symptoms, Treatment, and More

Published: Feb 27, 2026
Author: Emily Miao, PharmD
Editor: Alyssa Haag, MD
Editor: Lily Guo, MD
Editor: Kelsey LaFayette, DNP, ARNP, FNP-C
Illustrator: Jung Hee Lee, MScBMC
7-day free trial

Go deeper with Osmosis

Osmosis is a learning platform with videos, questions, and AI tools to help you master topics like this.

4.8 · 12,000+ reviews
Watch quick, visual videos
Practice with Qbank-style questions
Use AI to explain, quiz, and review
Study anytime with the mobile app
Start free trial

No credit card · Cancel anytime

What is Job syndrome?

Job syndrome is a rare immune deficiency disorder characterized by recurrent skin and lung infections and severe eczema. One of its main features is that individuals present extremely high serum levels of immunoglobulin E, an antibody that’s primarily associated with allergic responses 

Job syndrome belongs to a group of primary immune deficiencies that are collectively known as hyperimmunoglobulin IgE syndromes (HIES). These conditions share elevated IgE levels and overlapping clinical features and are classified according to their inheritance pattern and underlying genetic changes.  

Learn deeper with Osmosis

Master this topic faster with videos, questions, and AI.

Used by 8M+ healthcare learners.

Start free trial

No credit card · Cancel anytime

What causes Job syndrome?

Job syndrome is caused by mutations in the signal transducer and activator of the transcription 3 (STAT3) gene, which encodes for a variety of cell signaling molecules (e.g., cytokines, hormones, and growth factors) that are involved in pathways responsible for regulating the body’s immune response. Specifically, mutations in the STAT3 gene result in defective Th17 cell differentiation and function. Th17 cells are a subset of helper T cells that defend against extracellular pathogens such as bacteria and fungi. They are also involved in the recruitment of neutrophils by the release of interferon-gamma, thereby regulating the body’s autoimmune response (i.e., downregulating the activation of self-reactive cells) and maintaining the integrity of mucosal barrier surfaces (e.g., gastrointestinal tract). Th17 cellular impairments result in an increase in susceptibility to infections 

STAT3 gene defects also lead to impaired Th9 cell differentiation and function. Th9 cells are another subset of helper T cells that produce IL-9, a cytokine  that plays a role in allergy, asthma, and autoimmune inflammation. It does so by recruiting eosinophils a white blood cell that protects the body from allergens, parasites, and foreign bacteria, which are important mediators in the pathophysiology of allergic asthma.  

Mutations in STAT3 gene are inherited in an autosomal dominant pattern, which means that a person only needs to inherit one altered copy of the gene to develop the condition. So, if a parent has the mutation, each child has a 50% chance of inheriting it, and the condition can affect both males and females equally. 

What are the signs and symptoms of Job syndrome?

The most characteristic features of Job syndrome are recurrent skin and lung infections, particularly caused by commensal skin flora like Staphylococcus aureus. Patients commonly develop “cold” skin abscesses, so called because they lack the usual signs of redness, warmth, and pain due to the impaired inflammatory response. Recurrent pneumonias are frequent and may lead to structural lung damage, including bronchiectasis, which refers to dilations of the lower airways. These infections typically begin in early childhood and tend to recur in adulthood despite treatment. 

Another manifestation is severe eczema, often resembling atopic dermatitis. The skin is chronically inflamed, itchy, and prone to secondary infections. 

Generalized physical findings seen in Job syndrome include deep-set eyes, broad nasal bridge, prominent forehead, and chin. There may also be skeletal and connective tissue disorders, such as joint hyperextensibility, retained primary teeth, scoliosis, osteopenia, and recurrent fractures after minimal trauma. Less common but clinically relevant manifestations include mucocutaneous candidiasis, chronic sinusitis or otitis, and an increased risk of vascular abnormalities, such as coronary or cerebral aneurysms. 

How is Job syndrome diagnosed?

Diagnosis of Job syndrome begins with a thorough review of symptoms and medical history, followed by confirmation via laboratory and molecular testing. Job syndrome is suspected in older children or adults with typical facial features, recurrent sinopulmonary infections, skin abscesses, and chronic eczema. A focused physical exam can help assess for any musculoskeletal abnormalities like scoliosis or hyperextensibility of joints.  

Laboratory testing typically reveals high serum levels of IgE (i.e., ranging from 1,000 to greater than 50,000 IU/mL), elevated eosinophil counts (i.e., 40 to 50 percent of total white blood cell count), and low or absent levels of Th17 cells. Molecular testing typically reveals a pathogenic variant of the STAT3 gene. While imaging is not required for the diagnosis, it may be helpful in the management of vascular disease like aneurysms, if present. 

How is Job syndrome treated?

The treatment of Job syndrome includes a multidisciplinary approach aimed at managing recurrent skin and sinopulmonary infections as well as supportive care measures that improve the individual's quality of life. Acute infections can be managed with tailored antibiotics to the specific organism (e.g., fluconazole for Candida spp.) and surgical drainage or debridement for refractory infections. Antibiotic prophylaxis with trimethoprim-sulfamethoxazole (TMP-SMX) can be useful in preventing further skin and sinopulmonary infections including community-acquired Staphylococcus spp.  

Other emerging immunomodulating therapies such as intravenous immunoglobulin (IVIG) and recombinant human interferon-gamma have shown benefits in select individuals, although further evidence is needed to establish their long-term efficacy. Biologic therapies, such as omalizumab (anti-IgE monoclonal antibody), have been explored in small studies for controlling severe eczema and reducing allergic inflammation. Experimental strategies targeting STAT3 signaling or gene therapy are under investigation but remain at the preclinical stage.

Non-immune complications also require attention. Osteoporosis can be treated with bisphosphonates (e.g., alendronate, risedronate), which increase bone mineral density. Early referral to a dental specialist to extract primary retained teeth is helpful and helps avoid long-term dental complications like delayed wound healing and jaw misalignment.  

Supportive care measures include proper skin care with emollients and avoidance of irritants, regular dental hygiene, and routine preventive vaccinations (e.g., pneumococcal and influenza vaccines) to reduce the risk of infection. Finally, genetic counseling can be offered to the individual and their family members to better understand their condition and potential risks for future generations. 

What are the most important facts to know about Job syndrome?

Job syndrome is a rare immune deficiency disorder characterized by recurrent skin and lung infections as well as severe eczema.  Job syndrome is caused by mutations in the STAT3 gene, which result in defective Th17 cell differentiation and function, leading to increased suscpetibility to infections. Diagnosis of Job syndrome begins with a thorough review of symptoms and medical history, followed by confirmation via laboratory and molecular testing. Treatment includes a multidisciplinary approach focused on the management of recurrent infections and supportive care measures that improve the individual's quality of life. Systemic antibiotics are used for the treatment and prevention of infections. IVIG and interferon-gamma are also emerging therapies but require further study. Genetic counseling and education can be offered to the individual and their family members. 

Key Takeaways

Definition 

Rare primary immune deficiency characterized by recurrent infections, eczema, and high IgE levels  

Causes 

- Genetic mutation in STAT3  

- Impaired immune defense against bacteria and fungi 

- Inherited in autosomal dominant pattern 

Signs and Symptoms 

- Recurrent skin abscesses and respiratory infections 

- Severe eczema from infancy 

- Characteristic facial features (broad nasal bridge, prominent forehead, deep-set eyes) 

- Skeletal/connective tissue abnormalities (joint hyperextensibility, scoliosis, fractures, osteopenia) 

Diagnosis 

- Laboratory testing: elevated serum IgE levels (>2000 IU/mL), eosinophilia 

- Genetic confirmation: STAT3 

Treatment 

- Management of infections with antibiotics and/or antifungals, surgical drainage 

- Emerging therapies: IVIG, recombinant interferon-gamma, off-label omalizumab  

- Supportive treatment: skin care, dental hygiene, vaccinations, genetic counseling 

Students say Osmosis is 100% worth it

Because Osmosis saves them time. Lowers stress. And actually helps them remember when it counts.

I used Osmosis to prepare for my first medical school licensing exam! Super helpful and interactive for people who may not do great with just pages of text info!

Cecilia Ruiz

Cecilia Ruiz

MD student

Sayan Misra

I have used Osmosis for about four years. Best thing I have ever used for my medical studies.

Sayan Misra

Sayan Misra

Med student

Osmosis videos are superior because they define simple concepts, tell a story with a clear progression, and provide context.

Jay Pate

Jay Pate

Dental student

References


AlYafie R, Velayutham D, van Panhuys N, Jithesh PV. The genetics of hyper IgE syndromes. Front Immunol. 2025;16:1516068. doi:10.3389/fimmu.2025.1516068 


Al-Shaikhly T, Ochs HD. Hyper IgE syndromes: clinical and molecular characteristics. Immunol Cell Biol. 2019;97(4):368-379. doi:10.1111/imcb.12209 


Bhutani N, Sharma U, Kumar A, Kajal P. Pediatric hyperimmunoglobulin E syndrome (Job’s syndrome) with STAT3 mutation: A case report. Ann Med Surg (Lond). 2021;66(102452):102452. doi:10.1016/j.amsu.2021.102452 


Meric Z, Aydin M, Demir Gumus D, Yucel E, Kiykim A. Understanding and managing hyper IgE syndromes. ImmunoTargets Ther. 2025;14:1233-1245. doi:10.2147/ITT.S532287